{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer", "complementary medicine", "integrative oncology", "medicinal plants", "natural products", "phytotherapy"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35630688", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "31"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "17"}], "Language": ["eng"], "ELocationID": ["3209", "10.3390/molecules27103209"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "10", "PubDate": {"Year": "2022", "Month": "May", "Day": "17"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Phytotherapy in Integrative Oncology-An Update of Promising Treatment Options.", "Abstract": {"AbstractText": ["Modern phytotherapy is part of today's conventional evidence-based medicine and the use of phytopharmaceuticals in integrative oncology is becoming increasingly popular. Approximately 40% of users of such phytopharmaceuticals are tumour patients. The present review provides an overview of the most important plants and nature-based compounds used in integrative oncology and illustrates their pharmacological potential in preclinical and clinical settings. A selection of promising anti-tumour plants and ingredients was made on the basis of scientific evidence and therapeutic practical relevance and included Boswellia, gingko, ginseng, ginger, and curcumin. In addition to these nominees, there is a large number of other interesting plants and plant ingredients that can be considered for the treatment of cancer diseases or for the treatment of tumour or tumour therapy-associated symptoms. Side effects and interactions are included in the discussion. However, with the regular and intended use of phytopharmaceuticals, the occurrence of adverse side effects is rather rare. Overall, the use of defined phytopharmaceuticals is recommended in the context of a rational integrative oncology approach."]}, "AuthorList": [{"Identifier": ["0000-0002-8641-5965"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 80, CH-4056 Basel, Switzerland."}], "LastName": "Zimmermann-Klemd", "ForeName": "Amy M", "Initials": "AM"}, {"Identifier": ["0000-0002-8675-1029"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland."}], "LastName": "Reinhardt", "ForeName": "Jakob K", "Initials": "JK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 80, CH-4056 Basel, Switzerland."}], "LastName": "Winker", "ForeName": "Moritz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 80, CH-4056 Basel, Switzerland."}], "LastName": "Gr\u00fcndemann", "ForeName": "Carsten", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Zingiber officinale"}, {"QualifierName": [], "DescriptorName": "Ginkgo biloba"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Integrative Oncology"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ferlay J., Colombet M., Soerjomataram I., Parkin D.M., Pi\u00f1eros M., Znaor A., Bray F. Cancer statistics for the year 2020: An overview. Int. J. Cancer. 2021;149:778\u2013789. doi: 10.1002/ijc.33588.", "ArticleIdList": ["10.1002/ijc.33588", "33818764"]}, {"Citation": "Arem H., Loftfield E. Cancer Epidemiology: A Survey of Modifiable Risk Factors for Prevention and Survivorship. Am. J. Lifestyle Med. 2018;12:200\u2013210. doi: 10.1177/1559827617700600.", "ArticleIdList": ["10.1177/1559827617700600", "PMC6124966", "30202392"]}, {"Citation": "Majeed H., Gupta V. StatPearls. StatPearls Publishing LLC; Treasure Island, FL, USA: 2022. Adverse Effects of Radiation Therapy."}, {"Citation": "Maeda H., Khatami M. Analyses of repeated failures in cancer therapy for solid tumors: Poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. Clin. Transl. Med. 2018;7:11. doi: 10.1186/s40169-018-0185-6.", "ArticleIdList": ["10.1186/s40169-018-0185-6", "PMC5852245", "29541939"]}, {"Citation": "Pak H., Maghsoudi L.H., Soltanian A., Gholami F. Surgical complications in colorectal cancer patients. Ann. Med. Surg. 2020;55:13\u201318. doi: 10.1016/j.amsu.2020.04.024.", "ArticleIdList": ["10.1016/j.amsu.2020.04.024", "PMC7229272", "32435475"]}, {"Citation": "Kroschinsky F., St\u00f6lzel F., von Bonin S., Beutel G., Kochanek M., Kiehl M., Schellongowski P. New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management. Crit. Care. 2017;21:89. doi: 10.1186/s13054-017-1678-1.", "ArticleIdList": ["10.1186/s13054-017-1678-1", "PMC5391608", "28407743"]}, {"Citation": "Gatenby R., Brown J. The Evolution and Ecology of Resistance in Cancer Therapy. Cold Spring Harb Perspect. Med. 2018;8:a033415. doi: 10.1101/cshperspect.a033415.", "ArticleIdList": ["10.1101/cshperspect.a033415", "PMC5830903", "28710258"]}, {"Citation": "Sarmento-Ribeiro A.B., Scorilas A., Gon\u00e7alves A.C., Efferth T., Trougakos I.P. The emergence of drug resistance to targeted cancer therapies: Clinical evidence. Drug Resist. Update. 2019;47:100646. doi: 10.1016/j.drup.2019.100646.", "ArticleIdList": ["10.1016/j.drup.2019.100646", "31733611"]}, {"Citation": "Lemonnier N., Zhou G.-B., Prasher B., Mukerji M., Chen Z., Brahmachari S.K., Noble D., Auffray C., Sagner M. Traditional Knowledge-based Medicine: A Review of History, Principles, and Relevance in the Present Context of P4 Systems Medicine. Prog. Prev. Med. 2017;2:e0011. doi: 10.1097/pp9.0000000000000011.", "ArticleIdList": ["10.1097/pp9.0000000000000011"]}, {"Citation": "Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E.H., et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015;33:1582\u20131614. doi: 10.1016/j.biotechadv.2015.08.001.", "ArticleIdList": ["10.1016/j.biotechadv.2015.08.001", "PMC4748402", "26281720"]}, {"Citation": "Appendino G., Fontana G., Pollastro F. Natural Products Drug Discovery. Compr. Nat. Prod. II Chem. Biol. 2010;3:205\u2013236."}, {"Citation": "David B., Wolfender J.-L., Dias D.A. The pharmaceutical industry and natural products: Historical status and new trends. Phytochem. Rev. 2015;14:299\u2013315. doi: 10.1007/s11101-014-9367-z.", "ArticleIdList": ["10.1007/s11101-014-9367-z"]}, {"Citation": "B\u00e4umler S. Heilpflanzenpraxis. Heute: Portr\u00e4ts-Rezepturen-Anwendung. Urban & Fischer bei Elsevier; M\u00fcnchen, Germany: 2006."}, {"Citation": "Kingston D.G.I. Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation. J. Nat. Prod. 2011;74:496\u2013511. doi: 10.1021/np100550t.", "ArticleIdList": ["10.1021/np100550t", "PMC3061248", "21138324"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Weaver B.A. How Taxol/paclitaxel kills cancer cells. Mol. Biol. Cell. 2014;25:2677\u20132681. doi: 10.1091/mbc.e14-04-0916.", "ArticleIdList": ["10.1091/mbc.e14-04-0916", "PMC4161504", "25213191"]}, {"Citation": "Gokduman K. Strategies Targeting DNA Topoisomerase I in Cancer Chemotherapy: Camptothecins, Nanocarriers for Camptothecins, Organic Non-Camptothecin Compounds and Metal Complexes. Curr. Drug Targets. 2016;17:1928\u20131939. doi: 10.2174/1389450117666160502151707.", "ArticleIdList": ["10.2174/1389450117666160502151707", "27138759"]}, {"Citation": "Asiimwe J.B., Nagendrappa P.B., Atukunda E.C., Kamatenesi M.M., Nambozi G., Tolo C.U., Ogwang P.E., Sarki A.M. Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis. Evid. Based Complement. Altern. Med. 2021;2021:9963038. doi: 10.1155/2021/9963038.", "ArticleIdList": ["10.1155/2021/9963038", "PMC8149249", "34055029"]}, {"Citation": "Damery S., Gratus C., Grieve R., Warmington S., Jones J., Routledge P., Greenfield S., Dowswell G., Sherriff J., Wilson S. The use of herbal medicines by people with cancer: A cross-sectional survey. Br. J. Cancer. 2011;104:927\u2013933. doi: 10.1038/bjc.2011.47.", "ArticleIdList": ["10.1038/bjc.2011.47", "PMC3065283", "21364591"]}, {"Citation": "Ocran Mattila P., Ahmad R., Hasan S.S., Babar Z.-U.-D. Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature. Front. Public Health. 2021;9:462. doi: 10.3389/fpubh.2021.628744.", "ArticleIdList": ["10.3389/fpubh.2021.628744", "PMC8120029", "33996712"]}, {"Citation": "Katzke V.A., Kaaks R., K\u00fchn T. Lifestyle and cancer risk. Cancer J. 2015;21:104\u2013110. doi: 10.1097/PPO.0000000000000101.", "ArticleIdList": ["10.1097/PPO.0000000000000101", "25815850"]}, {"Citation": "Song M., Giovannucci E. Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors among White Adults in the United States. JAMA Oncol. 2016;2:1154\u20131161. doi: 10.1001/jamaoncol.2016.0843.", "ArticleIdList": ["10.1001/jamaoncol.2016.0843", "PMC5016199", "27196525"]}, {"Citation": "Vijayvergia N., Denlinger C.S. Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed. J. Pers. Med. 2015;5:243\u2013263. doi: 10.3390/jpm5030243.", "ArticleIdList": ["10.3390/jpm5030243", "PMC4600146", "26147495"]}, {"Citation": "Wenigmann M. Phytotherapie: Arzneidrogen Phytopharmka Anwendung. Elsevier Health Sciences/Urban & Fischer, Elsevier; Munich, Germany: 2017."}, {"Citation": "Schilcher H., Kammerer S., Wegener T., Volkmann D., editors. Leitfaden Phytotherapie (Dritte Ausgabe) Urban & Fischer; Munich, Germany: 2007. Kapitel 1\u2014Grundlegendes zur rationalen Phytotherapie; pp. 1\u201330."}, {"Citation": "European Scientific Cooperative on Phytotherapy.  [(accessed on 1 April 2022)].  Available online:  https://escop.com/about-escop/"}, {"Citation": "World Health Organization . WHO Global Report on Traditional and Complementary Medicine 2019. World Health Organization; Geneva, Switzerland: 2019."}, {"Citation": "Ernst E. Harmless herbs? A review of the recent literature. Am. J. Med. 1998;104:170\u2013178. doi: 10.1016/S0002-9343(97)00397-5.", "ArticleIdList": ["10.1016/S0002-9343(97)00397-5", "9528737"]}, {"Citation": "Caesar L.K., Cech N.B. Synergy and antagonism in natural product extracts: When 1 + 1 does not equal 2. Nat. Prod. Rep. 2019;36:869\u2013888. doi: 10.1039/C9NP00011A.", "ArticleIdList": ["10.1039/C9NP00011A", "PMC6820002", "31187844"]}, {"Citation": "Mittal B., Tulsyan S., Kumar S., Mittal R.D., Agarwal G. Cytochrome P450 in Cancer Susceptibility and Treatment. Adv. Clin. Chem. 2015;71:77\u2013139.", "ArticleIdList": ["26411412"]}, {"Citation": "Fasinu P.S., Rapp G.K. Herbal Interaction with Chemotherapeutic Drugs-A Focus on Clinically Significant Findings. Front. Oncol. 2019;9:1356. doi: 10.3389/fonc.2019.01356.", "ArticleIdList": ["10.3389/fonc.2019.01356", "PMC6901834", "31850232"]}, {"Citation": "\u00d6zenver N., Efferth T. Integration of Phytochemicals and Phytotherapy into Cancer Precision Medicine. In: Bizzarri M., editor. Approaching Complex Diseases: Network-Based Pharmacology and Systems Approach in Bio-Medicine. Springer International Publishing; Cham, Switzerland: 2020. pp. 355\u2013392."}, {"Citation": "Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353\u2013356. doi: 10.1055/s-2006-957450.", "ArticleIdList": ["10.1055/s-2006-957450", "9619120"]}, {"Citation": "European Medicines Agency European Union Monographs and List Entries.  [(accessed on 1 April 2022)].  Available online:  https://www.ema.europa.eu/en/human-regulatory/herbal-products/european-union-monographs-list-entries."}, {"Citation": "European Scientific Cooperative on Phytotherapy about the Scientific Committee.  [(accessed on 1 April 2022)].  Available online:  https://escop.com/about-escop/scientific-committee/"}, {"Citation": "Zhong L., Li Y., Xiong L., Wang W., Wu M., Yuan T., Yang W., Tian C., Miao Z., Wang T., et al. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives. Signal Transduct. Target. Ther. 2021;6:201. doi: 10.1038/s41392-021-00572-w.", "ArticleIdList": ["10.1038/s41392-021-00572-w", "PMC8165101", "34054126"]}, {"Citation": "WHO . Consultation on Selected Medicinal Plants, WHO Monographs on Selected Medicinal Plants. World Health Organization; Geneva, Switzerland: 2006."}, {"Citation": "Gordaliza M. Natural products as leads to anticancer drugs. Clin. Transl. Oncol. 2007;9:767\u2013776. doi: 10.1007/s12094-007-0138-9.", "ArticleIdList": ["10.1007/s12094-007-0138-9", "18158980"]}, {"Citation": "McCune J.S., Hatfield A.J., Blackburn A.A., Leith P.O., Livingston R.B., Ellis G.K. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 2004;12:454\u2013462. doi: 10.1007/s00520-004-0598-1.", "ArticleIdList": ["10.1007/s00520-004-0598-1", "14991387"]}, {"Citation": "Ashraf M.A. Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature\u2019s Bounty. BioMed Res. Int. 2020;2020:8602879. doi: 10.1155/2020/8602879.", "ArticleIdList": ["10.1155/2020/8602879", "PMC7013350", "32076618"]}, {"Citation": "Moga M.A., Dimienescu O.G., B\u0103lan A., Dima L., Toma S.I., B\u00eegiu N.F., Blidaru A. Pharmacological and Therapeutic Properties of Punica granatum Phytochemicals: Possible Roles in Breast Cancer. Molecules. 2021;26:1054. doi: 10.3390/molecules26041054.", "ArticleIdList": ["10.3390/molecules26041054", "PMC7921999", "33671442"]}, {"Citation": "Shah N.R., Patel B.M. Secoisolariciresinol diglucoside rich extract of L. usitatissimum prevents diabetic colon cancer through inhibition of CDK4. Biomed. Pharm. 2016;83:733\u2013739. doi: 10.1016/j.biopha.2016.07.041.", "ArticleIdList": ["10.1016/j.biopha.2016.07.041", "27470575"]}, {"Citation": "Ali M., Iqbal R., Safdar M., Murtaza S., Mustafa G., Sajjad M., Bukhari S.A., Huma T. Antioxidant and antibacterial activities of Artemisia absinthium and Citrus paradisi extracts repress viability of aggressive liver cancer cell line. Mol. Biol. Rep. 2021;48:7703\u20137710. doi: 10.1007/s11033-021-06777-0.", "ArticleIdList": ["10.1007/s11033-021-06777-0", "34755263"]}, {"Citation": "Beynon R.A., Richmond R.C., Santos Ferreira D.L., Ness A.R., May M., Smith G.D., Vincent E.E., Adams C., Ala-Korpela M., W\u00fcrtz P., et al. Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial. Int. J. Cancer. 2019;144:1918\u20131928. doi: 10.1002/ijc.31929.", "ArticleIdList": ["10.1002/ijc.31929", "PMC6491994", "30325021"]}, {"Citation": "Chen P., Zhang W., Wang X., Zhao K., Negi D.S., Zhuo L., Qi M., Wang X., Zhang X. Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Medicine. 2015;94:e1260. doi: 10.1097/MD.0000000000001260.", "ArticleIdList": ["10.1097/MD.0000000000001260", "PMC4616444", "26287411"]}, {"Citation": "Almatroodi S.A., Almatroudi A., Khan A.A., Alhumaydhi F.A., Alsahli M.A., Rahmani A.H. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Molecules. 2020;25:3146. doi: 10.3390/molecules25143146.", "ArticleIdList": ["10.3390/molecules25143146", "PMC7397003", "32660101"]}, {"Citation": "Zaffaroni N., Beretta G.L. Resveratrol and Prostate Cancer: The Power of Phytochemicals. Curr. Med. Chem. 2021;28:4845\u20134862. doi: 10.2174/0929867328666201228124038.", "ArticleIdList": ["10.2174/0929867328666201228124038", "33371831"]}, {"Citation": "Heggie S., Bryant G.P., Tripcony L., Keller J., Rose P., Glendenning M., Heath J. A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs. 2002;25:442\u2013451. doi: 10.1097/00002820-200212000-00007.", "ArticleIdList": ["10.1097/00002820-200212000-00007", "12464836"]}, {"Citation": "Hoopfer D., Holloway C., Gabos Z., Alidrisi M., Chafe S., Krause B., Lees A., Mehta N., Tankel K., Strickland F., et al. Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy. Clin. Breast Cancer. 2015;15:181\u2013190.e4. doi: 10.1016/j.clbc.2014.12.006.", "ArticleIdList": ["10.1016/j.clbc.2014.12.006", "25619686"]}, {"Citation": "Olsen D.L., Raub W., Jr., Bradley C., Johnson M., Macias J.L., Love V., Markoe A. The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol. Nurs. Forum. 2001;28:543\u2013547.", "ArticleIdList": ["11338761"]}, {"Citation": "Williams M.S., Burk M., Loprinzi C.L., Hill M., Schomberg P.J., Nearhood K., O\u2019Fallon J.R., Laurie J.A., Shanahan T.G., Moore R.L., et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int. J. Radiat. Oncol. Biol. Phys. 1996;36:345\u2013349. doi: 10.1016/S0360-3016(96)00320-3.", "ArticleIdList": ["10.1016/S0360-3016(96)00320-3", "8892458"]}, {"Citation": "Mansouri P., Haghighi M., Beheshtipour N., Ramzi M. The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial. Int. J. Community Based Nurs. Midwifery. 2016;4:119\u2013126.", "ArticleIdList": ["PMC4876780", "27218109"]}, {"Citation": "Saberi-Karimian M., Katsiki N., Caraglia M., Boccellino M., Majeed M., Sahebkar A. Vascular endothelial growth factor: An important molecular target of curcumin. Crit. Rev. Food Sci. Nutr. 2019;59:299\u2013312. doi: 10.1080/10408398.2017.1366892.", "ArticleIdList": ["10.1080/10408398.2017.1366892", "28853916"]}, {"Citation": "da Costa Miranda V., Trufelli D.C., Santos J., Campos M.P., Nobuo M., da Costa Miranda M., Schlinder F., Riechelmann R., del Giglio A. Effectiveness of guaran\u00e1 (Paullinia cupana) for postradiation fatigue and depression: Results of a pilot double-blind randomized study. J. Altern. Complement. Med. 2009;15:431\u2013433. doi: 10.1089/acm.2008.0324.", "ArticleIdList": ["10.1089/acm.2008.0324", "19388866"]}, {"Citation": "de Oliveira Campos M.P., Riechelmann R., Martins L.C., Hassan B.J., Casa F.B., Del Giglio A. Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy. J. Altern. Complement. Med. 2011;17:505\u2013512. doi: 10.1089/acm.2010.0571.", "ArticleIdList": ["10.1089/acm.2010.0571", "21612429"]}, {"Citation": "del Giglio A.B., Cubero Dde I., Lerner T.G., Guariento R.T., de Azevedo R.G., Paiva H., Goldman C., Carelli B., Cruz F.M., Schindler F., et al. Purified dry extract of Paullinia cupana (guaran\u00e1) (PC-18) for chemotherapy-related fatigue in patients with solid tumors: An early discontinuation study. J. Diet Suppl. 2013;10:325\u2013334. doi: 10.3109/19390211.2013.830676.", "ArticleIdList": ["10.3109/19390211.2013.830676", "24237188"]}, {"Citation": "Martins S., Ferreira C.L., Del Giglio A. Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life. J. Diet Suppl. 2017;14:32\u201341. doi: 10.1080/19390211.2016.1193081.", "ArticleIdList": ["10.1080/19390211.2016.1193081", "27322597"]}, {"Citation": "Barton D.L., Atherton P.J., Bauer B.A., Moore D.F., Jr., Mattar B.I., Lavasseur B.I., Rowland K.M., Jr., Zon R.T., Lelindqwister N.A., Nagargoje G.G., et al. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: A phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5) J. Support Oncol. 2011;9:24\u201331. doi: 10.1016/j.suponc.2010.12.008.", "ArticleIdList": ["10.1016/j.suponc.2010.12.008", "PMC3052692", "21399726"]}, {"Citation": "Sch\u00e4fer A.M., Potterat O., Seibert I., Fertig O., Meyer Zu Schwabedissen H.E. Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1. Mol. Pharm. 2019;95:313\u2013323. doi: 10.1124/mol.118.114066.", "ArticleIdList": ["10.1124/mol.118.114066", "30573512"]}, {"Citation": "Cui Y.H., Zheng Y. A meta-analysis on the efficacy and safety of St John\u2019s wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults. Neuropsychiatr. Dis. Treat. 2016;12:1715\u20131723.", "ArticleIdList": ["PMC4946846", "27468236"]}, {"Citation": "Basar S. Phytochemical Investigations on Boswellia Species; Staats-und Universit\u00e4tsbibliothek Hamburg Carl von Ossietzky March 2005.  [(accessed on 1 April 2022)].  Available online:  https://ediss.sub.uni-hamburg.de/2005."}, {"Citation": "Seitz S. Isolierung und Strukturaufkl\u00e4rung von Entz\u00fcndungshemmenden Inhaltsstoffen aus Weihrauchharz. 2008.  [(accessed on 1 April 2022)].  Available online:  https://publikationen.sulb.uni-saarland.de2008."}, {"Citation": "Ammon H.P.T. Boswellic extracts and 11-keto-ss-boswellic acids prevent type 1 and type 2 diabetes mellitus by suppressing the expression of proinflammatory cytokines. Phytomedicine. 2019;63:153002. doi: 10.1016/j.phymed.2019.153002.", "ArticleIdList": ["10.1016/j.phymed.2019.153002", "31301539"]}, {"Citation": "Memorial Sloan Kettering Cancer Center about Herbs, Botanicals & Other Products.  [(accessed on 7 February 2021)].  Available online:  https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs."}, {"Citation": "Springer . Federal Office of Consumer Protectionand Food Safety: List of Substances of the Competent Federal Government and Federal State Authorities: Category \"Plants and Plant Parts\" (Stoffliste des Bundes und der Bundesl\u00e4nder: Kategorie \u201ePflanzen und Pflanzenteile\u201c) 1st ed. Springer; Cham, Switzerland: 2014."}, {"Citation": "Efferth T., Oesch F. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities. Semin. Cancer Biol. 2022;80:39\u201357. doi: 10.1016/j.semcancer.2020.01.015.", "ArticleIdList": ["10.1016/j.semcancer.2020.01.015", "32027979"]}, {"Citation": "Glaser T., Winter S., Groscurth P., Safayhi H., Sailer E.R., Ammon H.P., Schabet M., Weller M. Boswellic acids and malignant glioma: Induction of apoptosis but no modulation of drug sensitivity. Br. J. Cancer. 1999;80:756\u2013765. doi: 10.1038/sj.bjc.6690419.", "ArticleIdList": ["10.1038/sj.bjc.6690419", "PMC2362292", "10360653"]}, {"Citation": "Winking M., Sarikaya S., Rahmanian A., J\u00f6dicke A., B\u00f6ker D.K. Boswellic acids inhibit glioma growth: A new treatment option? J. Neurooncol. 2000;46:97\u2013103. doi: 10.1023/A:1006387010528.", "ArticleIdList": ["10.1023/A:1006387010528", "10894362"]}, {"Citation": "Hayes J.D., Dinkova-Kostova A.T., Tew K.D. Oxidative Stress in Cancer. Cancer Cell. 2020;38:167\u2013197. doi: 10.1016/j.ccell.2020.06.001.", "ArticleIdList": ["10.1016/j.ccell.2020.06.001", "PMC7439808", "32649885"]}, {"Citation": "Estrada A.C., Syrovets T., Pitterle K., Lunov O., B\u00fcchele B., Schimana-Pfeifer J., Schmidt T., Morad S.A., Simmet T. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells. Mol. Pharm. 2010;77:378\u2013387. doi: 10.1124/mol.109.060475.", "ArticleIdList": ["10.1124/mol.109.060475", "20018812"]}, {"Citation": "Park Y.S., Lee J.H., Bondar J., Harwalkar J.A., Safayhi H., Golubic M. Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells. Planta Med. 2002;68:397\u2013401. doi: 10.1055/s-2002-32090.", "ArticleIdList": ["10.1055/s-2002-32090", "12058313"]}, {"Citation": "Thorsteinsdottir S., Gudjonsson T., Nielsen O.H., Vainer B., Seidelin J.B. Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis. Nat. Rev. Gastroenterol. Hepatol. 2011;8:395\u2013404. doi: 10.1038/nrgastro.2011.96.", "ArticleIdList": ["10.1038/nrgastro.2011.96", "21647200"]}, {"Citation": "Roy N.K., Parama D., Banik K., Bordoloi D., Devi A.K., Thakur K.K., Padmavathi G., Shakibaei M., Fan L., Sethi G., et al. An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases. Int. J. Mol. Sci. 2019;20:4101. doi: 10.3390/ijms20174101.", "ArticleIdList": ["10.3390/ijms20174101", "PMC6747466", "31443458"]}, {"Citation": "Akincilar S.C., Khattar E., Boon P.L., Unal B., Fullwood M.J., Tergaonkar V. Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation. Cancer Discov. 2016;6:1276\u20131291. doi: 10.1158/2159-8290.CD-16-0177.", "ArticleIdList": ["10.1158/2159-8290.CD-16-0177", "27650951"]}, {"Citation": "Khattar E., Kumar P., Liu C.Y., Ak\u0131nc\u0131lar S.C., Raju A., Lakshmanan M., Maury J.J.P., Qiang Y., Li S., Tan E.Y., et al. Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression. J. Clin. Investig. 2016;126:4045\u20134060. doi: 10.1172/JCI86042.", "ArticleIdList": ["10.1172/JCI86042", "PMC5096818", "27643433"]}, {"Citation": "Roy N.K., Bordoloi D., Monisha J., Padmavathi G., Kotoky J., Golla R., Kunnumakkara A.B. Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer. Curr. Drug Targets. 2017;18:421\u2013435. doi: 10.2174/1389450117666160307145236.", "ArticleIdList": ["10.2174/1389450117666160307145236", "26953242"]}, {"Citation": "Xia D., Lou W., Fung K.M., Wolley C.L., Suhail M.M., Lin H.K. Cancer Chemopreventive Effects of Boswellia sacra Gum Resin Hydrodistillates on Invasive Urothelial Cell Carcinoma: Report of a Case. Integr. Cancer. 2017;16:605\u2013611. doi: 10.1177/1534735416664174.", "ArticleIdList": ["10.1177/1534735416664174", "PMC5739138", "27531547"]}, {"Citation": "Krishnaraju A.V., Sundararaju D., Vamsikrishna U., Suryachandra R., Machiraju G., Sengupta K., Trimurtulu G. Safety and toxicological evaluation of Aflapin: A novel Boswellia-derived anti-inflammatory product. Toxicol. Mech. Methods. 2010;20:556\u2013563. doi: 10.3109/15376516.2010.497978.", "ArticleIdList": ["10.3109/15376516.2010.497978", "20874664"]}, {"Citation": "Kirste S., Treier M., Wehrle S.J., Becker G., Abdel-Tawab M., Gerbeth K., Hug M.J., Lubrich B., Grosu A.L., Momm F. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: A prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer. 2011;117:3788\u20133795. doi: 10.1002/cncr.25945.", "ArticleIdList": ["10.1002/cncr.25945", "21287538"]}, {"Citation": "Lalithakumari K., Krishnaraju A.V., Sengupta K., Subbaraju G.V., Chatterjee A. Safety and Toxicological Evaluation of a Novel, Standardized 3-O-Acetyl-11-keto-beta-Boswellic Acid (AKBA)-Enriched Boswellia serrata Extract (5-Loxin(R)) Toxicol. Mech. Methods. 2006;16:199\u2013226. doi: 10.1080/15376520600620232.", "ArticleIdList": ["10.1080/15376520600620232", "20021046"]}, {"Citation": "Togni S., Maramaldi G., Bonetta A., Giacomelli L., Di Pierro F. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: A randomized placebo controlled trial. Eur. Rev. Med. Pharm. Sci. 2015;19:1338\u20131344.", "ArticleIdList": ["25967706"]}, {"Citation": "Dobat K., Dressendorfer W. Leonhart Fuchs: The New Herbal of 1543. Taschen; K\u00f6ln, Germany: 2001."}, {"Citation": "Schad F., Thronicke A., Merkle A., Steele M.L., Kr\u00f6z M., Herbstreit C., Matthes H. Implementation of an Integrative Oncological Concept in the Daily Care of a German Certified Breast Cancer Center. Complement. Med. Res. 2018;25:85\u201391. doi: 10.1159/000478655.", "ArticleIdList": ["10.1159/000478655", "29510405"]}, {"Citation": "Drozdoff L., Klein E., Kiechle M., Paepke D. Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy. BMC Complement. Altern. Med. 2018;18:259. doi: 10.1186/s12906-018-2325-3.", "ArticleIdList": ["10.1186/s12906-018-2325-3", "PMC6154925", "30249217"]}, {"Citation": "Steele M.L., Axtner J., Happe A., Kr\u00f6z M., Matthes H., Schad F. Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients. Evid. Based Complement Altern. Med. 2014;2014:724258. doi: 10.1155/2014/724258.", "ArticleIdList": ["10.1155/2014/724258", "PMC3929984", "24672577"]}, {"Citation": "Urech K., Jaggy C., Schaller G. 12. Viscotoxin and mistletoe lectin contents in Viscum album L.\u2014pharmaceutical implications. Phytomedicine: Int. J. Phytother. Phytopharm. 2007;14:S16."}, {"Citation": "Schaller G., Urech K., Giannattasio M. Cytotoxicity of Different Viscotoxins and Extracts from the European Subspecies of Viscum album L. Phytother. Res. 1996;10:473\u2013477. doi: 10.1002/(SICI)1099-1573(199609)10:6<473::AID-PTR879>3.0.CO;2-Q.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199609)10:6<473::AID-PTR879>3.0.CO;2-Q"]}, {"Citation": "Schaller G., Urech K., Grazi G., Giannattasio M. Viscotoxin Composition of the three European Subspecies of Viscum album. Planta Med. 1998;64:677\u2013678. doi: 10.1055/s-2006-957553.", "ArticleIdList": ["10.1055/s-2006-957553", "17253311"]}, {"Citation": "Kleinsimon S., Kauczor G., Jaeger S., Eggert A., Seifert G., Delebinski C. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs. BMC Complementary Altern. Med. 2017;17:26. doi: 10.1186/s12906-016-1545-7.", "ArticleIdList": ["10.1186/s12906-016-1545-7", "PMC5219806", "28061770"]}, {"Citation": "Park R., Kim M.S., So H.S., Jung B.H., Moon S.R., Chung S.Y., Ko C.B., Kim B.R., Chung H.T. Activation of c-Jun N-terminal kinase 1 (JNK1) in mistletoe lectin II-induced apoptosis of human myeloleukemic U937 cells. Biochem. Pharm. 2000;60:1685\u20131691. doi: 10.1016/S0006-2952(00)00482-2.", "ArticleIdList": ["10.1016/S0006-2952(00)00482-2", "11077051"]}, {"Citation": "Elluru S., Duong Van Huyen J.P., Delignat S., Prost F., Bayry J., Kazatchkine M.D., Kaveri S.V. Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador. Arzneimittelforschung. 2006;56:461\u2013466. doi: 10.1055/s-0031-1296813.", "ArticleIdList": ["10.1055/s-0031-1296813", "16927527"]}, {"Citation": "Elluru S.R., Duong Van Huyen J.-P., Wootla B., Delignat S., Prost F., Negi V., Kaveri S. Tumor regressive effects of Viscum album preparations. Exploration of immunomodulatory mechanisms. Medicina. 2007;67:85\u201389."}, {"Citation": "B\u00fcssing A., Scheer R., Bauer R., Becker H., Berg A.P., Fintelmann V. Viscum album L.\u2014Mechanismen der Zytotoxizit\u00e4t. Die Mistel in der Tumortherapie. KVC Verlag; Essen, Germany: 2001."}, {"Citation": "Klein R., Scheer R., Alban S., Becker H. Die Mistel in der Tumortherapie 2. KVC Verlag; Essen, Germany: 2009. Effekte von Mistelextrakten auf immunkompetente Zellen in vitro und in vivo."}, {"Citation": "Kienle G.S., Kiene H. Die Mistel in der Onkologie. Fakten und Konzeptionelle Grundlagen. Schattauer Verlag; Stuttgart, Germany: 2003. Vertr\u00e4glichkeit, Nebenwirkungen, \u00dcberempfindlichkeitsreaktionen, Toxizit\u00e4t; pp. 591\u2013607."}, {"Citation": "Huber R., Classen K., Werner M., Klein R. In vitro immunoreactivity towards lectin-rich or viscotoxin-rich mistletoe (Viscum album L.) extracts Iscador applied to healthy individuals. Arzneimittelforschung. 2006;56:447\u2013456. doi: 10.1055/s-0031-1296811.", "ArticleIdList": ["10.1055/s-0031-1296811", "16927525"]}, {"Citation": "Kienle G.S., Kiene H. Die Mistel in der Onkologie: Fakten und konzeptionelle Grundlagen. Schattauer Verlag; Stuttgart, Germany: 2003."}, {"Citation": "Els\u00e4sser-Beile U., Voss M., Sch\u00fchle R., Wetterauer U. Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro. J. Clin. Lab. Anal. 2000;14:255\u2013259. doi: 10.1002/1098-2825(20001212)14:6<255::AID-JCLA1>3.0.CO;2-J.", "ArticleIdList": ["10.1002/1098-2825(20001212)14:6<255::AID-JCLA1>3.0.CO;2-J", "PMC6808059", "11138605"]}, {"Citation": "Tabiasco J., Pont F., Fourni\u00e9 J.J., Vercellone A. Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity. Eur. J. Biochem. 2002;269:2591\u20132600. doi: 10.1046/j.1432-1033.2002.02932.x.", "ArticleIdList": ["10.1046/j.1432-1033.2002.02932.x", "12027898"]}, {"Citation": "Fischer A. Ph.D. Thesis. Tier\u00e4rztliche Hochschule Hannover; Hannover, Germany: Nov, 2006. Charakterisierung der Immunmodulatorischen Wirkung von Mistelpr\u00e4paraten auf Zellen des Immunsystems bei Rindern."}, {"Citation": "Steinborn C., Klemd A.M., Sanchez-Campillo A.S., Rieger S., Scheffen M., Sauer B., Garcia-K\u00e4ufer M., Urech K., Follo M., \u00dccker A., et al. Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model. PLoS ONE. 2017;12:e0181553. doi: 10.1371/journal.pone.0181553.", "ArticleIdList": ["10.1371/journal.pone.0181553", "PMC5515458", "28719632"]}, {"Citation": "Saha C., Das M., Stephen-Victor E., Friboulet A., Bayry J., Kaveri S.V. Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4\u207a T Cell Responses. Molecules. 2016;21:912. doi: 10.3390/molecules21070912.", "ArticleIdList": ["10.3390/molecules21070912", "PMC6273690", "27428940"]}, {"Citation": "Grossarth-Maticek R., Kiene H., Baumgartner S.M., Ziegler R. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: Prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern. Health Med. 2001;7", "ArticleIdList": ["11347286"]}, {"Citation": "Grossarth-Maticek R., Ziegler R. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador. Arzneimittelforschung. 2007;57:665\u2013678.", "ArticleIdList": ["18074761"]}, {"Citation": "Grossarth-Maticek R., Ziegler R. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador) Eur. J. Med. Res. 2008;13:107\u2013120.", "ArticleIdList": ["18499556"]}, {"Citation": "Cazacu M., Oniu T., Lungoci C., Mihailov A., Cipak A., Klinger R., Weiss T., Zarkovic N. The influence of isorel on the advanced colorectal cancer. Cancer Biother. Radiopharm. 2003;18:27\u201334. doi: 10.1089/108497803321269304.", "ArticleIdList": ["10.1089/108497803321269304", "12667306"]}, {"Citation": "Lenartz D., Dott U., Menzel J., Schierholz J.M., Beuth J. Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res. 2000;20:2073\u20132076.", "ArticleIdList": ["10928154"]}, {"Citation": "Tr\u00f6ger W., Galun D., Reif M., Schumann A., Stankovi\u0107 N., Mili\u0107evi\u0107 M. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival. Eur. J. Cancer. 2013;49:3788\u20133797. doi: 10.1016/j.ejca.2013.06.043.", "ArticleIdList": ["10.1016/j.ejca.2013.06.043", "23890767"]}, {"Citation": "Dold U., Edler L., M\u00e4urer H.-C. Krebszusatztherapie beim fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom. Dtsch. Arztebl. Int. 1992;89:A-3797."}, {"Citation": "Salzer G., Danmayr E., Wutzlhofer F., Frey S. Adjuvante Iscador-Behandlung operierter nicht kleinzelliger Bronchuskarzinome. Dtsch. Z. Onkol. 1991;23:93\u201398."}, {"Citation": "Kleeberg U.R., Suciu S., Br\u00f6cker E.B., Ruiter D.J., Chartier C., Li\u00e9nard D., Marsden J., Schadendorf D., Eggermont A.M. Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis. Eur. J. Cancer. 2004;40:390\u2013402. doi: 10.1016/j.ejca.2003.07.004.", "ArticleIdList": ["10.1016/j.ejca.2003.07.004", "14746858"]}, {"Citation": "Grossarth-Maticek R., Ziegler R. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) Komplementmed. 2006;13:285\u2013292. doi: 10.1159/000095378.", "ArticleIdList": ["10.1159/000095378", "17057389"]}, {"Citation": "Grossarth-Maticek R., Ziegler R. Efficacy and safety of the long-term treatment of melanoma with a mistletoe preparation (Iscador) Schweiz. Z. Ganzheitsmed. 2007;19:325\u2013332. doi: 10.1159/000285940.", "ArticleIdList": ["10.1159/000285940"]}, {"Citation": "Grossarth-Maticek R., Ziegler R. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador) Komplementmed. 2007;14:140\u2013147. doi: 10.1159/000102956.", "ArticleIdList": ["10.1159/000102956", "17596694"]}, {"Citation": "Bar-Sela G., Wollner M., Hammer L., Agbarya A., Dudnik E., Haim N. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: A randomised phase II study. Eur. J. Cancer. 2013;49:1058\u20131064. doi: 10.1016/j.ejca.2012.11.007.", "ArticleIdList": ["10.1016/j.ejca.2012.11.007", "23218588"]}, {"Citation": "Steuer-Vogt M.K., Bonkowsky V., Ambrosch P., Scholz M., Neiss A., Strutz J., Hennig M., Lenarz T., Arnold W. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: A randomised controlled clinical trial. Eur. J. Cancer. 2001;37:23\u201331. doi: 10.1016/S0959-8049(00)00360-9.", "ArticleIdList": ["10.1016/S0959-8049(00)00360-9", "11165126"]}, {"Citation": "Goebell P., Otto T., Suhr J., R\u00fcbben H. Evaluation of an Unconventional Treatment Modality with Mistletoe Lectin to Prevent Recurrence of Superficial Bladder Cancer: A Randomized Phase ii Trial. J. Urol. 2002;168:72\u201375. doi: 10.1016/S0022-5347(05)64834-3.", "ArticleIdList": ["10.1016/S0022-5347(05)64834-3", "12050495"]}, {"Citation": "Borrelli E. Evaluation of the quality of life in breast cancer patients undergoing lectin standardized mistletoe therapy. Minerva Med. 2001;92:105\u2013107."}, {"Citation": "Semiglasov V.F., Stepula V.V., Dudov A., Lehmacher W., Mengs U. The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: A randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res. 2004;24:1293\u20131302.", "ArticleIdList": ["15154663"]}, {"Citation": "Semiglazov V.F., Stepula V.V., Dudov A., Schnitker J., Mengs U. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: A randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res. 2006;26:1519\u20131529.", "ArticleIdList": ["16619567"]}, {"Citation": "Piao B.K., Wang Y.X., Xie G.R., Mansmann U., Matthes H., Beuth J., Lin H.S. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res. 2004;24:303\u2013309.", "ArticleIdList": ["15015612"]}, {"Citation": "Mei N., Guo X., Ren Z., Kobayashi D., Wada K., Guo L. Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2017;35:1\u201328. doi: 10.1080/10590501.2016.1278298.", "ArticleIdList": ["10.1080/10590501.2016.1278298", "PMC6373469", "28055331"]}, {"Citation": "DeFeudis F.V., Papadopoulos V., Drieu K. Ginkgo biloba extracts and cancer: A research area in its infancy. Fundam. Clin. Pharm. 2003;17:405\u2013417. doi: 10.1046/j.1472-8206.2003.00156.x.", "ArticleIdList": ["10.1046/j.1472-8206.2003.00156.x", "12914542"]}, {"Citation": "Sagar S.M., Yance D., Wong R.K. Natural health products that inhibit angiogenesis: A potential source for investigational new agents to treat cancer-Part 1. Curr. Oncol. 2006;13:14\u201326. doi: 10.3747/co.v13i1.77.", "ArticleIdList": ["10.3747/co.v13i1.77", "PMC1891166", "17576437"]}, {"Citation": "Qiao L., Zheng J., Jin X., Wei G., Wang G., Sun X., Li X. Ginkgolic acid inhibits the invasiveness of colon cancer cells through AMPK activation. Oncol. Lett. 2017;14:5831\u20135838. doi: 10.3892/ol.2017.6967.", "ArticleIdList": ["10.3892/ol.2017.6967", "PMC5661430", "29113214"]}, {"Citation": "Tsai J.-R., Liu P.-L., Chen Y.-H., Chou S.-H., Yang M.-C., Cheng Y.-J., Hwang J.-J., Yin W.-H., Chong I.-W. Ginkgo biloba Extract Decreases Non-Small Cell Lung Cancer Cell Migration by Downregulating Metastasis-Associated Factor Heat-Shock Protein 27. PLoS ONE. 2014;9:e91331. doi: 10.1371/journal.pone.0091331.", "ArticleIdList": ["10.1371/journal.pone.0091331", "PMC3950153", "24618684"]}, {"Citation": "Han D., Cao C., Su Y., Wang J., Sun J., Chen H., Xu A. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/\u03b2-catenin-VEGF signaling pathway in Lewis lung cancer. J. Ethnopharmacol. 2016;192:406\u2013412. doi: 10.1016/j.jep.2016.09.018.", "ArticleIdList": ["10.1016/j.jep.2016.09.018", "27649680"]}, {"Citation": "Wang Y., Lv J., Cheng Y., Du J., Chen D., Li C., Zhang J. Apoptosis Induced by Ginkgo biloba (EGb761) in Melanoma Cells Is Mcl-1-Dependent. PLoS ONE. 2015;10:e0124812. doi: 10.1371/journal.pone.0124812.", "ArticleIdList": ["10.1371/journal.pone.0124812", "PMC4393283", "25860257"]}, {"Citation": "Kim K.S., Rhee K.H., Yoon J.H., Lee J.G., Lee J.H., Yoo J.B. Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol. 2005;41:383\u2013389. doi: 10.1016/j.oraloncology.2004.09.013.", "ArticleIdList": ["10.1016/j.oraloncology.2004.09.013", "15792610"]}, {"Citation": "Czauderna C., Palestino-Dominguez M., Castven D., Becker D., Zanon-Rodriguez L., Hajduk J., Mahn F.L., Herr M., Strand D., Strand S., et al. Ginkgo biloba induces different gene expression signatures and oncogenic pathways in malignant and non-malignant cells of the liver. PLoS ONE. 2018;13:e0209067. doi: 10.1371/journal.pone.0209067.", "ArticleIdList": ["10.1371/journal.pone.0209067", "PMC6303069", "30576355"]}, {"Citation": "Fu Z., Lin L., Liu S., Qin M., He S., Zhu L., Huang J. Ginkgo Biloba Extract Inhibits Metastasis and ERK/Nuclear Factor kappa B (NF-\u03baB) Signaling Pathway in Gastric Cancer. Med. Sci. Monit. 2019;25:6836\u20136845. doi: 10.12659/MSM.915146.", "ArticleIdList": ["10.12659/MSM.915146", "PMC6753842", "31509521"]}, {"Citation": "Liang J.-R., Yang H. Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS. Biomed. Pharmacother. 2020;125:109585. doi: 10.1016/j.biopha.2019.109585.", "ArticleIdList": ["10.1016/j.biopha.2019.109585", "32106377"]}, {"Citation": "Kang J.W., Kim J.H., Song K., Kim S.H., Yoon J.H., Kim K.S. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother. Res. 2010;24((Suppl. 1)):S77\u2013S82. doi: 10.1002/ptr.2913.", "ArticleIdList": ["10.1002/ptr.2913", "19585476"]}, {"Citation": "Weakley S.M., Wang X., Mu H., L\u00fc J., Lin P.H., Yao Q., Chen C. Ginkgolide A-gold nanoparticles inhibit vascular smooth muscle proliferation and migration in vitro and reduce neointimal hyperplasia in a mouse model. J. Surg. Res. 2011;171:31\u201339. doi: 10.1016/j.jss.2011.03.018.", "ArticleIdList": ["10.1016/j.jss.2011.03.018", "PMC3161135", "21571322"]}, {"Citation": "Wang X., Shao Q.H., Zhou H., Wu J.L., Quan W.Q., Ji P., Yao Y.W., Li D., Sun Z.J. Ginkgolide B inhibits lung cancer cells promotion via beclin-1-dependent autophagy. BMC Complement. Med. 2020;20:194. doi: 10.1186/s12906-020-02980-x.", "ArticleIdList": ["10.1186/s12906-020-02980-x", "PMC7310550", "32576183"]}, {"Citation": "Zhi Y., Pan J., Shen W., He P., Zheng J., Zhou X., Lu G., Chen Z., Zhou Z. Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion through MicroRNA-223-3p. Cell Physiol. Biochem. 2016;39:1787\u20131794. doi: 10.1159/000447878.", "ArticleIdList": ["10.1159/000447878", "27744452"]}, {"Citation": "Yang M.H., Ha I.J., Lee S.G., Lee J., Um J.Y., Ahn K.S. Ginkgolide C promotes apoptosis and abrogates metastasis of colorectal carcinoma cells by targeting Wnt/\u03b2-catenin signaling pathway. IUBMB Life. 2021;73:1222\u20131234. doi: 10.1002/iub.2532.", "ArticleIdList": ["10.1002/iub.2532", "34273236"]}, {"Citation": "Liu J., Geng Z., Zhang Y., Alharbi S.A., Shi Y. Sesquiterpenoid bilobalide inhibits gastric carcinoma cell growth and induces apoptosis both in vitro and in vivo models. J. Biochem. Mol. Toxicol. 2021;35:e22723. doi: 10.1002/jbt.22723.", "ArticleIdList": ["10.1002/jbt.22723", "33511709"]}, {"Citation": "Xu A.H., Chen H.S., Sun B.C., Xiang X.R., Chu Y.F., Zhai F., Jia L.C. Therapeutic mechanism of ginkgo biloba exocarp polysaccharides on gastric cancer. World J. Gastroenterol. 2003;9:2424\u20132427. doi: 10.3748/wjg.v9.i11.2424.", "ArticleIdList": ["10.3748/wjg.v9.i11.2424", "PMC4656514", "14606069"]}, {"Citation": "Ye B., Aponte M., Dai Y., Li L., Ho M.C., Vitonis A., Edwards D., Huang T.N., Cramer D.W. Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence. Cancer Lett. 2007;251:43\u201352. doi: 10.1016/j.canlet.2006.10.025.", "ArticleIdList": ["10.1016/j.canlet.2006.10.025", "17194528"]}, {"Citation": "Biggs M.L., Sorkin B.C., Nahin R.L., Kuller L.H., Fitzpatrick A.L. Ginkgo biloba and risk of cancer: Secondary analysis of the Ginkgo Evaluation of Memory (GEM) Study. Pharm. Drug Saf. 2010;19:694\u2013698. doi: 10.1002/pds.1979.", "ArticleIdList": ["10.1002/pds.1979", "PMC2917376", "20582906"]}, {"Citation": "Barton D.L., Burger K., Novotny P.J., Fitch T.R., Kohli S., Soori G., Wilwerding M.B., Sloan J.A., Kottschade L.A., Rowland K.M., Jr., et al. The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Support Care Cancer. 2013;21:1185\u20131192. doi: 10.1007/s00520-012-1647-9.", "ArticleIdList": ["10.1007/s00520-012-1647-9", "PMC3587364", "23150188"]}, {"Citation": "Koch E. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: Considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine. 2005;12:10\u201316. doi: 10.1016/j.phymed.2004.02.002.", "ArticleIdList": ["10.1016/j.phymed.2004.02.002", "15693702"]}, {"Citation": "Grosse Y., Loomis D., Lauby-Secretan B., El Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Guha N., Baan R., Mattock H., Straif K. Carcinogenicity of some drugs and herbal products. Lancet Oncol. 2013;14:807\u2013808. doi: 10.1016/S1470-2045(13)70329-2.", "ArticleIdList": ["10.1016/S1470-2045(13)70329-2", "24058961"]}, {"Citation": "International Agency for Research on Cancer IARC Monographs on the Identification of Carcinogenic Hazards to Human.  [(accessed on 1 April 2022)].  Available online:  https://monographs.iarc.who.int."}, {"Citation": "Choi E.J., Bae S.M., Ahn W.S. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch. Pharm. Res. 2008;31:1281\u20131285. doi: 10.1007/s12272-001-2107-0.", "ArticleIdList": ["10.1007/s12272-001-2107-0", "18958418"]}, {"Citation": "Unlu A., Nayir E., Kirca O., Ay H., Ozdogan M. Ginseng and cancer. J. Buon. 2016;21:1383\u20131387.", "ArticleIdList": ["28039696"]}, {"Citation": "Mochizuki M., Yoo Y.C., Matsuzawa K., Sato K., Saiki I., Tono-oka S., Samukawa K., Azuma I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol. Pharm. Bull. 1995;18:1197\u20131202. doi: 10.1248/bpb.18.1197.", "ArticleIdList": ["10.1248/bpb.18.1197", "8845804"]}, {"Citation": "Wang C.Z., Anderson S., Du W., He T.C., Yuan C.S. Red ginseng and cancer treatment. Chin. J. Nat. Med. 2016;14:7\u201316.", "ArticleIdList": ["26850342"]}, {"Citation": "King M.L., Murphy L.L. American ginseng (Panax quinquefolius L.) extract alters mitogen-activated protein kinase cell signaling and inhibits proliferation of MCF-7 cells. J. Exp. Oncol. 2007;6:147\u2013155.", "ArticleIdList": ["17407973"]}, {"Citation": "Li B., Wang C.Z., He T.C., Yuan C.S., Du W. Antioxidants potentiate American ginseng-induced killing of colorectal cancer cells. Cancer Lett. 2010;289:62\u201370. doi: 10.1016/j.canlet.2009.08.002.", "ArticleIdList": ["10.1016/j.canlet.2009.08.002", "PMC2824022", "19716228"]}, {"Citation": "Jin Y., Hofseth A.B., Cui X., Windust A.J., Poudyal D., Chumanevich A.A., Matesic L.E., Singh N.P., Nagarkatti M., Nagarkatti P.S., et al. American Ginseng Suppresses Colitis through p53-Mediated Apoptosis of Inflammatory Cells. Cancer Prev. Res. 2010;3:339\u2013347. doi: 10.1158/1940-6207.CAPR-09-0116.", "ArticleIdList": ["10.1158/1940-6207.CAPR-09-0116", "PMC2833220", "20179294"]}, {"Citation": "Kang A., Hao H., Zheng X., Liang Y., Xie Y., Xie T., Dai C., Zhao Q., Wu X., Xie L., et al. Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. J. Neuroinflamm. 2011;8:100. doi: 10.1186/1742-2094-8-100.", "ArticleIdList": ["10.1186/1742-2094-8-100", "PMC3169467", "21843370"]}, {"Citation": "Lee S., Kwon M.C., Jang J.P., Sohng J.K., Jung H.J. The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells. Int. J. Oncol. 2017;51:414\u2013424. doi: 10.3892/ijo.2017.4054.", "ArticleIdList": ["10.3892/ijo.2017.4054", "PMC5505016", "28656196"]}, {"Citation": "L\u00fc J.M., Yao Q., Chen C. Ginseng compounds: An update on their molecular mechanisms and medical applications. Curr. Vasc. Pharm. 2009;7:293\u2013302. doi: 10.2174/157016109788340767.", "ArticleIdList": ["10.2174/157016109788340767", "PMC2928028", "19601854"]}, {"Citation": "Ahuja A., Kim J.H., Kim J.H., Yi Y.S., Cho J.Y. Functional role of ginseng-derived compounds in cancer. J. Ginseng Res. 2018;42:248\u2013254. doi: 10.1016/j.jgr.2017.04.009.", "ArticleIdList": ["10.1016/j.jgr.2017.04.009", "PMC6026353", "29983605"]}, {"Citation": "Liu Y., Yu S., Xing X., Qiao J., Yin Y., Wang J., Liu M., Zhang W. Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex. Mol. Med. Rep. 2021;24:873. doi: 10.3892/mmr.2021.12513.", "ArticleIdList": ["10.3892/mmr.2021.12513", "PMC8569524", "34713297"]}, {"Citation": "Chen C., Wang Y.S., Zhang E.T., Li G.A., Liu W.Y., Li Y., Jin Y.H. (20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells. Int. J. Mol. Sci. 2021;22:13170. doi: 10.3390/ijms222313170.", "ArticleIdList": ["10.3390/ijms222313170", "PMC8658384", "34884975"]}, {"Citation": "Park J.E., Kim H.W., Yun S.H., Kim S.J. Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation. J. Ginseng Res. 2021;45:754\u2013762. doi: 10.1016/j.jgr.2021.08.006.", "ArticleIdList": ["10.1016/j.jgr.2021.08.006", "PMC8570952", "34764730"]}, {"Citation": "Jeon H., Huynh D.T.N., Baek N., Nguyen T.L.L., Heo K.S. Ginsenoside-Rg2 affects cell growth via regulating ROS-mediated AMPK activation and cell cycle in MCF-7 cells. Phytomedicine. 2021;85:153549. doi: 10.1016/j.phymed.2021.153549.", "ArticleIdList": ["10.1016/j.phymed.2021.153549", "33819767"]}, {"Citation": "Sun X., Zhao P., Li H., Liu Y., Wang T., Cheng Y. Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer. J. Oncol. 2021;2021:9715154. doi: 10.1155/2021/9715154.", "ArticleIdList": ["10.1155/2021/9715154", "PMC8487371", "34608390"]}, {"Citation": "Lev-Ari S., Starr A.N., Vexler A., Kalich-Philosoph L., Yoo H.S., Kwon K.R., Yadgar M., Bondar E., Bar-Shai A., Volovitz I., et al. Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer. Food Funct. 2021;12:8068\u20138077. doi: 10.1039/D1FO00643F.", "ArticleIdList": ["10.1039/D1FO00643F", "34286798"]}, {"Citation": "Hwang S.K., Jeong Y.J., Cho H.J., Park Y.Y., Song K.H., Chang Y.C. Rg3-enriched red ginseng extract promotes lung cancer cell apoptosis and mitophagy by ROS production. J. Ginseng Res. 2022;46:138\u2013146. doi: 10.1016/j.jgr.2021.05.005.", "ArticleIdList": ["10.1016/j.jgr.2021.05.005", "PMC8753562", "35058730"]}, {"Citation": "Chen C., Lv Q., Li Y., Jin Y.H. The Anti-Tumor Effect and Underlying Apoptotic Mechanism of Ginsenoside Rk1 and Rg5 in Human Liver Cancer Cells. Molecules. 2021;26:3926. doi: 10.3390/molecules26133926.", "ArticleIdList": ["10.3390/molecules26133926", "PMC8271777", "34199025"]}, {"Citation": "Li Y., Wang P., Zou Z., Pan Q., Li X., Liang Z., Li L., Lin Y., Peng X., Zhang R., et al. Ginsenoside (20S)-protopanaxatriol induces non-protective autophagy and apoptosis by inhibiting Akt/mTOR signaling pathway in triple-negative breast cancer cells. Biochem. Biophys. Res. Commun. 2021;583:184\u2013191. doi: 10.1016/j.bbrc.2021.10.067.", "ArticleIdList": ["10.1016/j.bbrc.2021.10.067", "34749235"]}, {"Citation": "Cui Y., Shu X.O., Gao Y.T., Cai H., Tao M.H., Zheng W. Association of ginseng use with survival and quality of life among breast cancer patients. Am. J. Epidemiol. 2006;163:645\u2013653. doi: 10.1093/aje/kwj087.", "ArticleIdList": ["10.1093/aje/kwj087", "16484447"]}, {"Citation": "Donovan K.A., Jacobsen P.B. The Fatigue Symptom Inventory: A systematic review of its psychometric properties. Support Care Cancer. 2010;19:169\u2013185. doi: 10.1007/s00520-010-0989-4.", "ArticleIdList": ["10.1007/s00520-010-0989-4", "20824482"]}, {"Citation": "Jiang S.L., Liu H.J., Liu Z.C., Liu N., Liu R., Kang Y.R., Ji J.G., Zhang C., Hua B.J., Kang S.J. Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy. Chin. J. Integr. Med. 2017;23:331\u2013337. doi: 10.1007/s11655-015-2146-x.", "ArticleIdList": ["10.1007/s11655-015-2146-x", "26142337"]}, {"Citation": "Barton D.L., Soori G.S., Bauer B.A., Sloan J.A., Johnson P.A., Figueras C., Duane S., Mattar B., Liu H., Atherton P.J., et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: A randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer. 2010;18:179\u2013187. doi: 10.1007/s00520-009-0642-2.", "ArticleIdList": ["10.1007/s00520-009-0642-2", "PMC3911883", "19415341"]}, {"Citation": "Shuman-Paretsky M.J., Belser-Ehrlich J., Holtzer R. Psychometric properties of the Brief Fatigue Inventory in community-dwelling older adults. Arch. Phys. Med. Rehabil. 2014;95:1533\u20131539. doi: 10.1016/j.apmr.2014.03.026.", "ArticleIdList": ["10.1016/j.apmr.2014.03.026", "PMC4124821", "24742938"]}, {"Citation": "Mahomoodally M.F., Aumeeruddy M.Z., Rengasamy K.R.R., Roshan S., Hammad S., Pandohee J., Hu X., Zengin G. Ginger and its active compounds in cancer therapy: From folk uses to nano-therapeutic applications. Semin. Cancer Biol. 2021;69:140\u2013149. doi: 10.1016/j.semcancer.2019.08.009.", "ArticleIdList": ["10.1016/j.semcancer.2019.08.009", "31412298"]}, {"Citation": "European Medicines Agency Community Herbal Monograph on Zingiber Officinale Roscoe, Rhizoma.  [(accessed on 1 April 2022)].  Available online:  https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-zingiber-officinale-roscoe-rhizoma_en.pdf."}, {"Citation": "Ali B.H., Blunden G., Tanira M.O., Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem. Toxicol. 2008;46:409\u2013420. doi: 10.1016/j.fct.2007.09.085.", "ArticleIdList": ["10.1016/j.fct.2007.09.085", "17950516"]}, {"Citation": "Saha A., Blando J., Silver E., Beltran L., Sessler J., DiGiovanni J. 6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-\u03baB signaling. Cancer Prev. Res. 2014;7:627\u2013638. doi: 10.1158/1940-6207.CAPR-13-0420.", "ArticleIdList": ["10.1158/1940-6207.CAPR-13-0420", "24691500"]}, {"Citation": "Kim H.-W., Oh D.-H., Jung C., Kwon D.-D., Lim Y.-C. Apoptotic Effects of 6-Gingerol in LNCaP Human Prostate Cancer Cells. Soonchunhyang Med. Sci. 2011;17:75\u201379. doi: 10.15746/sms.11.017.", "ArticleIdList": ["10.15746/sms.11.017"]}, {"Citation": "Hung J.Y., Hsu Y.L., Li C.T., Ko Y.C., Ni W.C., Huang M.S., Kuo P.L. 6-Shogaol, an active constituent of dietary ginger, induces autophagy by inhibiting the AKT/mTOR pathway in human non-small cell lung cancer A549 cells. J. Agric. Food Chem. 2009;57:9809\u20139816. doi: 10.1021/jf902315e.", "ArticleIdList": ["10.1021/jf902315e", "19799425"]}, {"Citation": "Ling H., Yang H., Tan S.H., Chui W.K., Chew E.H. 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-\u03baB activation. Br. J. Pharm. 2010;161:1763\u20131777. doi: 10.1111/j.1476-5381.2010.00991.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00991.x", "PMC3010581", "20718733"]}, {"Citation": "Hu S.M., Yao X.H., Hao Y.H., Pan A.H., Zhou X.W. 8-Gingerol regulates colorectal cancer cell proliferation and migration through the EGFR/STAT/ERK pathway. Int. J. Oncol. 2020;56:390\u2013397. doi: 10.3892/ijo.2019.4934.", "ArticleIdList": ["10.3892/ijo.2019.4934", "31814036"]}, {"Citation": "Ryu M.J., Chung H.S. [10]-Gingerol induces mitochondrial apoptosis through activation of MAPK pathway in HCT116 human colon cancer cells. Vitr. Cell Dev. Biol. Anim. 2015;51:92\u2013101. doi: 10.1007/s11626-014-9806-6.", "ArticleIdList": ["10.1007/s11626-014-9806-6", "25148824"]}, {"Citation": "Fuzer A.M., Martin A., Becceneri A.B., da Silva J.A., Vieira P.C., Cominetti M.R. [10]-Gingerol Affects Multiple Metastatic Processes and Induces Apoptosis in MDAMB- 231 Breast Tumor Cells. Anticancer Agents Med. Chem. 2019;19:645\u2013654. doi: 10.2174/1871520618666181029125607.", "ArticleIdList": ["10.2174/1871520618666181029125607", "30370858"]}, {"Citation": "Martin A., Fuzer A.M., Becceneri A.B., da Silva J.A., Tomasin R., Denoyer D., Kim S.H., McIntyre K.A., Pearson H.B., Yeo B., et al. [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo. Oncotarget. 2017;8:72260\u201372271. doi: 10.18632/oncotarget.20139.", "ArticleIdList": ["10.18632/oncotarget.20139", "PMC5641128", "29069785"]}, {"Citation": "Rasmussen A., Murphy K., Hoskin D.W. 10-Gingerol Inhibits Ovarian Cancer Cell Growth by Inducing G2 Arrest. Adv. Pharm. Bull. 2019;9:685\u2013689. doi: 10.15171/apb.2019.080.", "ArticleIdList": ["10.15171/apb.2019.080", "PMC6912173", "31857975"]}, {"Citation": "Fu J., Chen H., Soroka D.N., Warin R.F., Sang S. Cysteine-Conjugated Metabolites of Ginger Components, Shogaols, Induce Apoptosis through Oxidative Stress-Mediated p53 Pathway in Human Colon Cancer Cells. J. Agric. Food Chem. 2014;62:4632\u20134642. doi: 10.1021/jf501351r.", "ArticleIdList": ["10.1021/jf501351r", "PMC4033655", "24786146"]}, {"Citation": "Kaewtunjai N., Wongpoomchai R., Imsumran A., Pompimon W., Athipornchai A., Suksamrarn A., Lee T.R., Tuntiwechapikul W. Ginger Extract Promotes Telomere Shortening and Cellular Senescence in A549 Lung Cancer Cells. ACS Omega. 2018;3:18572\u201318581. doi: 10.1021/acsomega.8b02853.", "ArticleIdList": ["10.1021/acsomega.8b02853", "PMC6988994", "32010796"]}, {"Citation": "Bae W.Y., Choi J.S., Kim J.E., Park C., Jeong J.W. Zingerone suppresses angiogenesis via inhibition of matrix metalloproteinases during tumor development. Oncotarget. 2016;7:47232\u201347241. doi: 10.18632/oncotarget.10030.", "ArticleIdList": ["10.18632/oncotarget.10030", "PMC5216937", "27323807"]}, {"Citation": "Lee H.S., Seo E.Y., Kang N.E., Kim W.K. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J. Nutr. Biochem. 2008;19:313\u2013319. doi: 10.1016/j.jnutbio.2007.05.008.", "ArticleIdList": ["10.1016/j.jnutbio.2007.05.008", "17683926"]}, {"Citation": "Weng C.J., Wu C.F., Huang H.W., Ho C.T., Yen G.C. Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol. Nutr. Food Res. 2010;54:1618\u20131627. doi: 10.1002/mnfr.201000108.", "ArticleIdList": ["10.1002/mnfr.201000108", "20521273"]}, {"Citation": "Tjendraputra E., Tran V.H., Liu-Brennan D., Roufogalis B.D., Duke C.C. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg. Chem. 2001;29:156\u2013163. doi: 10.1006/bioo.2001.1208.", "ArticleIdList": ["10.1006/bioo.2001.1208", "11437391"]}, {"Citation": "van Breemen R.B., Tao Y., Li W. Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale) Fitoterapia. 2011;82:38\u201343. doi: 10.1016/j.fitote.2010.09.004.", "ArticleIdList": ["10.1016/j.fitote.2010.09.004", "PMC3018740", "20837112"]}, {"Citation": "Anderson W.F., Umar A., Hawk E.T. Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opin. Pharm. 2003;4:2193\u20132204. doi: 10.1517/14656566.4.12.2193.", "ArticleIdList": ["10.1517/14656566.4.12.2193", "14640918"]}, {"Citation": "Citronberg J., Bostick R., Ahearn T., Turgeon D.K., Ruffin M.T., Djuric Z., Sen A., Brenner D.E., Zick S.M. Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: Results from a pilot, randomized, and controlled trial. Cancer Prev. Res. 2013;6:271\u2013281. doi: 10.1158/1940-6207.CAPR-12-0327.", "ArticleIdList": ["10.1158/1940-6207.CAPR-12-0327", "PMC3618532", "23303903"]}, {"Citation": "Shokri F., Mostafa Gharebaghi P., Esfahani A., Sayyah-Melli M., Jafari Shobeiri M., Ouladsahebmadarek E., Ghojazadeh M. Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients. Int. J. Women\u2019s Health Reprod. Sci. 2016;5:324\u2013331. doi: 10.15296/ijwhr.2017.55.", "ArticleIdList": ["10.15296/ijwhr.2017.55"]}, {"Citation": "Lee J., Oh H. Ginger as an antiemetic modality for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Oncol. Nurs. Forum. 2013;40:163\u2013170. doi: 10.1188/13.ONF.163-170.", "ArticleIdList": ["10.1188/13.ONF.163-170", "23448741"]}, {"Citation": "Marx W., McCarthy A.L., Ried K., McKavanagh D., Vitetta L., Sali A., Lohning A., Isenring E. The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial. Nutrients. 2017;9:867. doi: 10.3390/nu9080867.", "ArticleIdList": ["10.3390/nu9080867", "PMC5579660", "28805667"]}, {"Citation": "Oppenheimer A. Turmeric (curcumin) in biliary diseases. Lancet. 1937;229:619\u2013621. doi: 10.1016/S0140-6736(00)98193-5.", "ArticleIdList": ["10.1016/S0140-6736(00)98193-5"]}, {"Citation": "Tayyem R.F., Heath D.D., Al-Delaimy W.K., Rock C.L. Curcumin content of turmeric and curry powders. Nutr. Cancer. 2006;55:126\u2013131. doi: 10.1207/s15327914nc5502_2.", "ArticleIdList": ["10.1207/s15327914nc5502_2", "17044766"]}, {"Citation": "Stohs S.J., Chen O., Ray S.D., Ji J., Bucci L.R., Preuss H.G. Highly Bioavailable Forms of Curcumin and Promising Avenues for Curcumin-Based Research and Application: A Review. Molecules. 2020;25:1397. doi: 10.3390/molecules25061397.", "ArticleIdList": ["10.3390/molecules25061397", "PMC7144558", "32204372"]}, {"Citation": "Kuo M.-L., Huang T.-S., Lin J.-K. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 1996;1317:95\u2013100. doi: 10.1016/S0925-4439(96)00032-4.", "ArticleIdList": ["10.1016/S0925-4439(96)00032-4", "8950193"]}, {"Citation": "Liu Y., Wu Y.M., Yu Y., Cao C.S., Zhang J.H., Li K., Zhang P.Y. Curcumin and resveratrol in combination modulate drug-metabolizing enzymes as well as antioxidant indices during lung carcinogenesis in mice. Hum. Exp. Toxicol. 2015;34:620\u2013627. doi: 10.1177/0960327114551396.", "ArticleIdList": ["10.1177/0960327114551396", "25632966"]}, {"Citation": "Gupta N., Verma K., Nalla S., Kulshreshtha A., Lall R., Prasad S. Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin. Molecules. 2020;25:5390. doi: 10.3390/molecules25225390.", "ArticleIdList": ["10.3390/molecules25225390", "PMC7698794", "33217990"]}, {"Citation": "Moldogazieva N.T., Lutsenko S.V., Terentiev A.A. Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy. Cancer Res. 2018;78:6040\u20136047. doi: 10.1158/0008-5472.CAN-18-0980.", "ArticleIdList": ["10.1158/0008-5472.CAN-18-0980", "30327380"]}, {"Citation": "Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012;2012:137289. doi: 10.5402/2012/137289.", "ArticleIdList": ["10.5402/2012/137289", "PMC3483701", "23119185"]}, {"Citation": "Liu Y., Wu Y.M., Zhang P.Y. Protective effects of curcumin and quercetin during benzo(a)pyrene induced lung carcinogenesis in mice. Eur. Rev. Med. Pharm. Sci. 2015;19:1736\u20131743.", "ArticleIdList": ["26004618"]}, {"Citation": "Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., Nakanishi Y., Uetake C., Kato K., Kato T., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446\u2013450. doi: 10.1038/nature12721.", "ArticleIdList": ["10.1038/nature12721", "24226770"]}, {"Citation": "Kaiko G.E., Ryu S.H., Koues O.I., Collins P.L., Solnica-Krezel L., Pearce E.J., Pearce E.L., Oltz E.M., Stappenbeck T.S. The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites. Cell. 2016;165:1708\u20131720. doi: 10.1016/j.cell.2016.05.018.", "ArticleIdList": ["10.1016/j.cell.2016.05.018", "PMC5026192", "27264604"]}, {"Citation": "Li Z., Gao Y., Li L., Xie S. Curcumin Inhibits Papillary Thyroid Cancer Cell Proliferation by Regulating lncRNA LINC00691. Anal. Cell Pathol. 2022;2022:5946670. doi: 10.1155/2022/5946670.", "ArticleIdList": ["10.1155/2022/5946670", "PMC8898135", "35256924"]}, {"Citation": "Guneydas G., Topcul M.R. Antiproliferative Effects of Curcumin Different Types of Breast Cancer. Asian Pac. J. Cancer Prev. 2022;23:911\u2013917. doi: 10.31557/APJCP.2022.23.3.911.", "ArticleIdList": ["10.31557/APJCP.2022.23.3.911", "35345363"]}, {"Citation": "Yavuz T\u00fcrel G., \u015eahin Calapo\u011flu N., Bayram D., \u00d6zg\u00f6\u00e7men M., To\u011fay V.A., Evgen T\u00fcl\u00fcceo\u011flu E. Curcumin induces apoptosis through caspase dependent pathway in human colon carcinoma cells. Mol. Biol. Rep. 2022;49:1351\u20131360. doi: 10.1007/s11033-021-06965-y.", "ArticleIdList": ["10.1007/s11033-021-06965-y", "34806141"]}, {"Citation": "Tro\u0161elj K.G., Samar\u017eija I., Tomljanovi\u0107 M., Kujund\u017ei\u0107 R.N., \u0110akovi\u0107 N., Mojze\u0161 A. Implementing Curcumin in Translational Oncology Research. Molecules. 2020;25:5240. doi: 10.3390/molecules25225240.", "ArticleIdList": ["10.3390/molecules25225240", "PMC7698148", "33182817"]}, {"Citation": "Cruz-Correa M., Hylind L.M., Marrero J.H., Zahurak M.L., Murray-Stewart T., Casero R.A., Jr., Montgomery E.A., Iacobuzio-Donahue C., Brosens L.A., Offerhaus G.J., et al. Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis. Gastroenterology. 2018;155:668\u2013673. doi: 10.1053/j.gastro.2018.05.031.", "ArticleIdList": ["10.1053/j.gastro.2018.05.031", "PMC6120769", "29802852"]}, {"Citation": "Hejazi J., Rastmanesh R., Taleban F.A., Molana S.H., Hejazi E., Ehtejab G., Hara N. Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study. Nutr. Cancer. 2016;68:77\u201385. doi: 10.1080/01635581.2016.1115527.", "ArticleIdList": ["10.1080/01635581.2016.1115527", "26771294"]}, {"Citation": "Mansourian A., Amanlou M., Shirazian S., Moosavian Jahromi Z., Amirian A. The effect of \u201cCurcuma Longa\u201d topical gel on radiation-induced oral mucositis in patients with head and neck cancer. Int. J. Radiat. Res. 2015;13:269\u2013274."}, {"Citation": "Rao S., Dinkar C., Vaishnav L.K., Rao P., Rai M.P., Fayad R., Baliga M.S. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study. Integr. Cancer. 2014;13:201\u2013210. doi: 10.1177/1534735413503549.", "ArticleIdList": ["10.1177/1534735413503549", "24165896"]}, {"Citation": "Roe A.L., Wilcox R., Price J.M., Li L., Dai H., Freeman K.M., Friley W.W., Herman A.G., Black C.B., Brouwer K.R., et al. An Evaluation of Potential Inhibition of CYP3A4/5 and CYP2C9 Enzymatic Activity by Boswellia serrata Extract. Appl. Vitr. Toxicol. 2019;5:34\u201346. doi: 10.1089/aivt.2018.0023.", "ArticleIdList": ["10.1089/aivt.2018.0023"]}, {"Citation": "Schink M., Dehus O. Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities. BMC Complement. Altern. Med. 2017;17:521. doi: 10.1186/s12906-017-2028-1.", "ArticleIdList": ["10.1186/s12906-017-2028-1", "PMC5715639", "29202738"]}, {"Citation": "Ando Y., Fuse E., Figg W.D. Thalidomide metabolism by the CYP2C subfamily. Clin. Cancer Res. 2002;8:1964\u20131973.", "ArticleIdList": ["12060642"]}, {"Citation": "Goey A.K., Mooiman K.D., Beijnen J.H., Schellens J.H., Meijerman I. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients. Cancer Treat Rev. 2013;39:773\u2013783. doi: 10.1016/j.ctrv.2012.12.008.", "ArticleIdList": ["10.1016/j.ctrv.2012.12.008", "23394826"]}, {"Citation": "European Medicines Agency Ginseng Radix.  [(accessed on 7 February 2021)].  Available online:  https://www.ema.europa.eu/en/medicines/herbal/ginseng-radix."}, {"Citation": "Langhammer A.J., Nilsen O.G. In vitro inhibition of human CYP1A2, CYP2D6, and CYP3A4 by six herbs commonly used in pregnancy. Phytother. Res. 2014;28:603\u2013610. doi: 10.1002/ptr.5037.", "ArticleIdList": ["10.1002/ptr.5037", "23843424"]}, {"Citation": "Li M., Chen P.Z., Yue Q.X., Li J.Q., Chu R.A., Zhang W., Wang H. Pungent ginger components modulates human cytochrome P450 enzymes in vitro. Acta Pharm. Sin. 2013;34:1237\u20131242. doi: 10.1038/aps.2013.49.", "ArticleIdList": ["10.1038/aps.2013.49", "PMC4003154", "23770984"]}, {"Citation": "Mukkavilli R., Gundala S.R., Yang C., Donthamsetty S., Cantuaria G., Jadhav G.R., Vangala S., Reid M.D., Aneja R. Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics. PLoS ONE. 2014;9:e108386. doi: 10.1371/journal.pone.0108386.", "ArticleIdList": ["10.1371/journal.pone.0108386", "PMC4177392", "25251219"]}, {"Citation": "Shamsi S., Tran H., Tan R.S.J., Tan Z.J., Lim L.Y. Curcumin, Piperine, and Capsaicin: A Comparative Study of Spice-Mediated Inhibition of Human Cytochrome P450 Isozyme Activities. Drug Metab. Dispos. 2017;45:49. doi: 10.1124/dmd.116.073213.", "ArticleIdList": ["10.1124/dmd.116.073213", "27821437"]}, {"Citation": "Waghray D., Zhang Q. Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment. J. Med. Chem. 2018;61:5108\u20135121. doi: 10.1021/acs.jmedchem.7b01457.", "ArticleIdList": ["10.1021/acs.jmedchem.7b01457", "PMC6281405", "29251920"]}, {"Citation": "Weber C.C., Reising K., M\u00fcller W.E., Schubert-Zsilavecz M., Abdel-Tawab M. Modulation of Pgp function by boswellic acids. Planta Med. 2006;72:507\u2013513. doi: 10.1055/s-2006-931536.", "ArticleIdList": ["10.1055/s-2006-931536", "16773534"]}, {"Citation": "Hellum B.H., Nilsen O.G. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin. Pharm. Toxicol. 2008;102:466\u2013475. doi: 10.1111/j.1742-7843.2008.00227.x.", "ArticleIdList": ["10.1111/j.1742-7843.2008.00227.x", "18331390"]}, {"Citation": "Kwon H.-Y., Kim E.-H., Kim S.-W., Kim S.-N., Park J.-D., Rhee D.-K. Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation. Arch. Pharmacal Res. 2008;31:171\u2013177. doi: 10.1007/s12272-001-1137-y.", "ArticleIdList": ["10.1007/s12272-001-1137-y", "18365686"]}, {"Citation": "Nabekura T., Kamiyama S., Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem. Biophys. Res. Commun. 2005;327:866\u2013870. doi: 10.1016/j.bbrc.2004.12.081.", "ArticleIdList": ["10.1016/j.bbrc.2004.12.081", "15649425"]}, {"Citation": "Anuchapreeda S., Leechanachai P., Smith M.M., Ambudkar S.V., Limtrakul P.-n. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem. Pharmacol. 2002;64:573\u2013582. doi: 10.1016/S0006-2952(02)01224-8.", "ArticleIdList": ["10.1016/S0006-2952(02)01224-8", "12167476"]}, {"Citation": "Gu C., Qiao J., Zhu M., Du J., Shang W., Yin W., Wang W., Han M., Lu W. Preliminary evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells. Am. J. Chin. Med. 2013;41:443\u2013458. doi: 10.1142/S0192415X13500328.", "ArticleIdList": ["10.1142/S0192415X13500328", "23548131"]}, {"Citation": "Afsharmoghadam N., Haghighatian Z., Mazdak H., Mirkheshti N., Mehrabi Koushki R., Alavi S.A. Concentration- Dependent Effects of Curcumin on 5-Fluorouracil Efficacy in Bladder Cancer Cells. Asian Pac. J. Cancer Prev. 2017;18:3225\u20133230.", "ArticleIdList": ["PMC5980875", "29281876"]}, {"Citation": "Asai A., Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci. 2000;67:2785\u20132793. doi: 10.1016/S0024-3205(00)00868-7.", "ArticleIdList": ["10.1016/S0024-3205(00)00868-7", "11105995"]}, {"Citation": "Ferguson J.E., Orlando R.A. Curcumin reduces cytotoxicity of 5-Fluorouracil treatment in human breast cancer cells. J. Med. Food. 2015;18:497\u2013502. doi: 10.1089/jmf.2013.0086.", "ArticleIdList": ["10.1089/jmf.2013.0086", "24476216"]}, {"Citation": "Jain A., Rani V. Assessment of herb-drug synergy to combat doxorubicin induced cardiotoxicity. Life Sci. 2018;205:97\u2013106. doi: 10.1016/j.lfs.2018.05.021.", "ArticleIdList": ["10.1016/j.lfs.2018.05.021", "29752960"]}, {"Citation": "Jung K.H., Lee J.H., Park J.W., Moon S.H., Cho Y.S., Choe Y.S., Lee K.H. Effects of curcumin on cancer cell mitochondrial function and potential monitoring with \u00b9\u2078F-FDG uptake. Oncol. Rep. 2016;35:861\u2013868. doi: 10.3892/or.2015.4460.", "ArticleIdList": ["10.3892/or.2015.4460", "26718769"]}, {"Citation": "Moiseeva E.P., Almeida G.M., Jones G.D., Manson M.M. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol. Cancer. 2007;6:3071\u20133079. doi: 10.1158/1535-7163.MCT-07-0117.", "ArticleIdList": ["10.1158/1535-7163.MCT-07-0117", "18025290"]}, {"Citation": "Ravindranath V., Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 1980;16:259\u2013265. doi: 10.1016/0300-483X(80)90122-5.", "ArticleIdList": ["10.1016/0300-483X(80)90122-5", "7423534"]}, {"Citation": "Seehofer D., Schirmeier A., Bengmark S., Carter J., Koch M., Glanemann M., N\u00fcssler A.K., Neuhaus P., Menger M.D. Inhibitory effect of curcumin on early liver regeneration following partial hepatectomy in rats. J. Surg. Res. 2009;155:195\u2013200. doi: 10.1016/j.jss.2008.09.011.", "ArticleIdList": ["10.1016/j.jss.2008.09.011", "19482305"]}, {"Citation": "Somasundaram S., Edmund N.A., Moore D.T., Small G.W., Shi Y.Y., Orlowski R.Z. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002;62:3868\u20133875.", "ArticleIdList": ["12097302"]}, {"Citation": "Yan Y.D., Kim D.H., Sung J.H., Yong C.S., Choi H.G. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. Int. J. Pharm. 2010;399:116\u2013120. doi: 10.1016/j.ijpharm.2010.08.015.", "ArticleIdList": ["10.1016/j.ijpharm.2010.08.015", "20727390"]}, {"Citation": "Zhao J.-Y., Lu N., Yan Z., Wang N. SAHA and curcumin combinations co-enhance histone acetylation in human cancer cells but operate antagonistically in exerting cytotoxic effects. J. Asian Nat. Prod. Res. 2010;12:335\u2013348. doi: 10.1080/10286021003730348.", "ArticleIdList": ["10.1080/10286021003730348", "20496190"]}, {"Citation": "Rotblatt M. Herbal Medicine: Expanded Commission E Monographs. Ann. Intern. Med. 2000;133:487. doi: 10.7326/0003-4819-133-6-200009190-00031.", "ArticleIdList": ["10.7326/0003-4819-133-6-200009190-00031"]}, {"Citation": "Ammon H.P. Boswellic Acids and Their Role in Chronic Inflammatory Diseases. Adv. Exp. Med. Biol. 2016;928:291\u2013327.", "ArticleIdList": ["27671822"]}, {"Citation": "Kienle G.S., Grugel R., Kiene H. Safety of higher dosages of Viscum album L. in animals and humans\u2014Systematic review of immune changes and safety parameters. BMC Complement. Altern. Med. 2011;11:72. doi: 10.1186/1472-6882-11-72.", "ArticleIdList": ["10.1186/1472-6882-11-72", "PMC3180269", "21871125"]}, {"Citation": "Ginseng . Drugs and Lactation Database (LactMed) National Library of Medicine (US); Bethesda, MD, USA: 2006."}, {"Citation": "Roland P.D., Nerg\u00e5rd C.S. Ginkgo biloba\u2014effect, adverse events and drug interaction. Tidsskr. Nor. Laegeforen. 2012;132:956\u2013959. doi: 10.4045/tidsskr.11.0780.", "ArticleIdList": ["10.4045/tidsskr.11.0780", "22562327"]}, {"Citation": "Anh N.H., Kim S.J., Long N.P., Min J.E., Yoon Y.C., Lee E.G., Kim M., Kim T.J., Yang Y.Y., Son E.Y., et al. Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials. Nutrients. 2020;12:157. doi: 10.3390/nu12010157.", "ArticleIdList": ["10.3390/nu12010157", "PMC7019938", "31935866"]}, {"Citation": "Hewlings S.J., Kalman D.S. Curcumin: A Review of Its Effects on Human Health. Foods. 2017;6:92. doi: 10.3390/foods6100092.", "ArticleIdList": ["10.3390/foods6100092", "PMC5664031", "29065496"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "12"}, {"Year": "2022", "Month": "5", "Day": "2"}, {"Year": "2022", "Month": "5", "Day": "10"}, {"Year": "2022", "Month": "5", "Day": "28", "Hour": "1", "Minute": "34"}, {"Year": "2022", "Month": "5", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["35630688", "PMC9143079", "10.3390/molecules27103209", "molecules27103209"]}}], "PubmedBookArticle": []}